Divyashakti Reports Profit Decline While Divi's Laboratories Posts Quarterly and Annual Gains
57 minutes agoBusiness
37LENS
3 Sources
TBNthebalanced.news

Divyashakti Reports Profit Decline While Divi's Laboratories Posts Quarterly and Annual Gains

Divyashakti reported an 82.98% decline in standalone net profit to Rs 0.08 crore for the quarter ended March 2026, with sales falling 52.33% to Rs 8.71 crore. For the full year, net profit dropped 58.66% to Rs 1.05 crore. In contrast, Divi's Laboratories saw a 13.44% rise in consolidated net profit to Rs 751 crore for the same quarter, with sales increasing 9.52% to Rs 2,831 crore. Its full-year net profit grew 17.21% to Rs 2,568 crore, supported by a 12.82% sales increase.

Political Bias
0%100%0%
Sentiment
58%
AI analysis of 3 sources · Published under editorial oversight by The Balanced News

AI Analysis

Political bias across 3 sources
Left 0% Center 100% Right 0%

The articles focus on financial performance without political framing. Both companies' results are presented factually, with no political viewpoints or commentary. The coverage is strictly business-oriented, reflecting corporate earnings and market data without ideological perspectives.

Sentiment — Neutral (58/100)

The sentiment across the articles is mixed, reflecting contrasting financial outcomes. Divyashakti's significant profit and sales declines convey a negative tone, while Divi's Laboratories' growth in profit and sales imparts a positive tone. The overall coverage balances these opposing trends without emotional language.

How 3 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

Coverage timeline

businessstandard broke this story on 23 May, 07:50 am. Other outlets followed.

  1. 1
    businessstandard23 May, 07:50 am
    Divi's Laboratories consolidated net profit rises 13.44 in the March 2026 quarter
  2. 2
    businessstandard23 May, 07:50 am
    Divyashakti standalone net profit declines 82.98 in the March 2026 quarter
  3. 3
    economictimes23 May, 08:33 am
    Divi's Laboratories Q4 Results: Cons PAT grows 13 YoY to Rs 751 crore, revenue up 10 ; Rs 30 per share dividend announced

Lens Score breakdown

37/100
Public interest0/100
Coverage gap100%

Story is receiving appropriate media attention relative to public interest.

Who's involved

Institutions and figures named across source coverage.

Corporate
Exide IndustriesDivi's LaboratoriesDivyashaktiIndigo PaintsCube Highways TrustRBL BankEmirates NBDNuvama Wealth

Story context

Category
Business
Sources analysed
3
Last analysed
23 May 2026
Key entities
CroreIndian rupeeRBL BankExide IndustriesIndiGoEmirates NBDNational Stock Exchange of IndiaDivi's LaboratoriesNet incomeDividendFiscal yearEquity (finance)